Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H13Cl2N5.ClH |
| Molecular Weight | 370.664 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.ClC1=CC=C(C=C1)\C=N\NC(=N)N\N=C\C2=CC=C(Cl)C=C2
InChI
InChIKey=LTWIBTYLSRDGHP-HCURTGQUSA-N
InChI=1S/C15H13Cl2N5.ClH/c16-13-5-1-11(2-6-13)9-19-21-15(18)22-20-10-12-3-7-14(17)8-4-12;/h1-10H,(H3,18,21,22);1H/b19-9+,20-10+;
| Molecular Formula | C15H13Cl2N5 |
| Molecular Weight | 334.203 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Robenidine (l,3-6ts (p-chlorobenzylidenamino) guanidine hydrochloride) is
an effective anticoccidial, first introduced by Kantor, Kennett, Waletzky &
Tomcufcik (1970). It does not affect the earliest stages in the coccidial life-cycle and
its main activity is against the almost mature first generation schizont. It is used as an aid in the prevention of coccidiosis caused by Eimeria mivati, E. brunetti, E. tenella, E. acervulina, E. maxima and E. necatrix in broiler chickens.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1118187
Curator's Comment: Robenidine was first introduced by Kantor, Kennett, Waletzky & Tomcufcik in 1970.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL612854 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1792230 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Robenz Approved UseFor the prevention of coccidiosis in broiler
chickens caused by and Eimeria acervulina,
E. mivati, E. maxima, E. brunetti, E. tenella, E. necatrix Launch Date2009 |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 4.0 |
inconclusive [IC50 3.4671 uM] | |||
Page: 79.0 |
no | |||
Page: 13.0 |
yes [IC50 13.8029 uM] | |||
Page: 79.0 |
yes [IC50 15.4871 uM] | |||
Page: 3.0 |
yes [IC50 2.1876 uM] | |||
Page: 4.0 |
yes [IC50 3.6258 uM] |
Sample Use Guides
Chickens: Mix 1 pound of Robenz® (Robenidine Hydrochloride) Type A Medicated Article in one ton of feed to provide 30 grams per ton (0.0033%) robenidine hydrochloride concentration in feed. Feed continuously as the sole ration.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26765953
Robenidine was active against MRSA and VRE with MIC's of 8.1 and 4.7 uM, respectively.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:18:26 GMT 2025
by
admin
on
Mon Mar 31 18:18:26 GMT 2025
|
| Record UNII |
8STT15Y392
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 556.580
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
||
|
NCI_THESAURUS |
C277
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m9641
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | Merck Index | ||
|
247-307-8
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
9570437
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
C76428
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
8STT15Y392
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
1311553
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | RxNorm | ||
|
8STT15Y392
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
DTXSID101017219
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
300000055093
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL97137
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY | |||
|
25875-50-7
Created by
admin on Mon Mar 31 18:18:26 GMT 2025 , Edited by admin on Mon Mar 31 18:18:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |